Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.
The current price of IART is $17.57 USD — it has decreased by -1.13% in the past 24 hours. Watch Integra Lifesciences stock price performance more closely on the chart.
What is Integra Lifesciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Integra Lifesciences stocks are traded under the ticker IART.
Is Integra Lifesciences stock price growing?▼
IART stock has risen by +3.6% compared to the previous week, the month change is a +24.47% rise, over the last year Integra Lifesciences has showed a +44.33% increase.
What is Integra Lifesciences market cap?▼
Today Integra Lifesciences has the market capitalization of 1.37B
When is the next Integra Lifesciences earnings date?▼
Integra Lifesciences is going to release the next earnings report on July 29, 2026.
What were Integra Lifesciences earnings last quarter?▼
IART earnings for the last quarter are 0.54 USD per share, whereas the estimation was 0.4 USD resulting in a +33.35% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Integra Lifesciences revenue for the last year?▼
Integra Lifesciences revenue for the last year amounts to 3.27B USD.
What is Integra Lifesciences net income for the last year?▼
IART net income for the last year is -1.03B USD.
How many employees does Integra Lifesciences have?▼
As of June 15, 2026, the company has 4,396 employees.
In which sector is Integra Lifesciences located?▼
Integra Lifesciences operates in the Health & Wellness sector.
When did Integra Lifesciences complete a stock split?▼
The last stock split for Integra Lifesciences was on January 04, 2017 with a ratio of 2:1.
Where is Integra Lifesciences headquartered?▼
Integra Lifesciences is headquartered in Princeton, United States.